Theradiag SA (ALTHE) - Cash Flow Conversion Efficiency

Latest as of June 2025: 1.404x

Based on the latest financial reports, Theradiag SA (ALTHE) has a cash flow conversion efficiency ratio of 1.404x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.56 Million ≈ $-4.17 Million USD) by net assets (€-2.54 Million ≈ $-2.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALTHE cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Theradiag SA - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Theradiag SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Theradiag SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theradiag SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Veru Inc NASDAQ:VERU	-0.166x
TREJHARA SOLUTIONS LIMITED NSE:TREJHARA	0.008x
SBF AG F:CY1K	N/A
Cyclone Metals Ltd AU:CLE	-0.088x
Dedicare AB (publ) ST:DEDI	-0.118x
Atlantaa Limited NSE:ATLANTAA	-0.073x
Li Kang Biomedical Co Ltd TWO:6242	0.077x
Farm Price Holdings Berhad KLSE:0304	0.039x

Annual Cash Flow Conversion Efficiency for Theradiag SA (2011–2024)

The table below shows the annual cash flow conversion efficiency of Theradiag SA from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Theradiag SA (ALTHE) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-114.00 ≈ $-133.28	€-2.91 Million ≈ $-3.40 Million	25535.088x	+5810417.91%
2023-12-31	€5.65 Million ≈ $6.61 Million	€-2.48 Million ≈ $-2.90 Million	-0.439x	+95.45%
2022-12-31	€544.87K ≈ $637.01K	€-5.27 Million ≈ $-6.16 Million	-9.665x	-416.71%
2021-12-31	€-1.27 Million ≈ $-1.49 Million	€-3.88 Million ≈ $-4.54 Million	3.052x	+197.46%
2020-12-31	€-3.24 Million ≈ $-3.79 Million	€-3.32 Million ≈ $-3.88 Million	1.026x	-97.79%
2019-12-31	€-79.73K ≈ $-93.21K	€-3.69 Million ≈ $-4.32 Million	46.321x	+420.83%
2018-12-31	€-531.93K ≈ $-621.88K	€-4.73 Million ≈ $-5.53 Million	8.894x	+554.82%
2017-12-31	€3.47 Million ≈ $4.06 Million	€-6.79 Million ≈ $-7.93 Million	-1.955x	-37.04%
2016-12-31	€5.58 Million ≈ $6.53 Million	€-7.97 Million ≈ $-9.31 Million	-1.427x	+78.31%
2015-12-31	€756.80K ≈ $884.78K	€-4.98 Million ≈ $-5.82 Million	-6.579x	-252.44%
2014-12-31	€2.77 Million ≈ $3.24 Million	€-5.18 Million ≈ $-6.05 Million	-1.867x	-275.77%
2013-12-31	€-3.80 Million ≈ $-4.45 Million	€-4.04 Million ≈ $-4.72 Million	1.062x	+111.88%
2012-12-31	€297.60K ≈ $347.92K	€-2.66 Million ≈ $-3.11 Million	-8.938x	-13.01%
2011-12-31	€120.37K ≈ $140.73K	€-952.02K ≈ $-1.11 Million	-7.909x	--

About Theradiag SA

PA:ALTHE France Medical Devices

Market Cap

$48.35 Million

€41.36 Million EUR

Market Cap Rank

#23058 Global

#365 in France

Share Price

€0.70

Change (1 day)

-6.67%

52-Week Range

€0.31 - €0.87

All Time High

€8.20